scholarly journals Genetic testing in Indian patients with Prader-Willi syndrome using methylation specific multiplex ligation dependent probe amplification (MS-MLPA)

Author(s):  
Vaman Khadilkar ◽  
Varsha Jagtap ◽  
John Mathew ◽  
Nikhil Phadke ◽  
Kavita Khatod ◽  
...  
Author(s):  
Chanita Prapasrat ◽  
Preyaporn Onsod ◽  
Veerawat Korkiatsakul ◽  
Budsaba Rerkamnuaychoke ◽  
Duangrurdee Wattanasirichaigoon ◽  
...  

AbstractPrader–Willi syndrome (PWS) is a genetic disorder caused by the expression disruption of genes on the paternally inherited allele of chromosome 15q11.2-q13. Apart from clinical diagnostic criteria, PWS is confirmed by genetic testing. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) is one of the molecular techniques used to analyze this syndrome. This study aimed to evaluate the concordance of the test results of MS-MLPA with conventional techniques in the diagnosis of PWS in Thai patients. Forty leftover specimens from routine genetic testing (MS-PCR and FISH) were tested to obtain MS-MLPA results. By comparison, perfect concordance was shown between the result of MS-MLPA and those of conventional techniques. In conclusion, MS-MLPA is an accurate and cost-effective assay that can be used to confirm PWS diagnosis with explicit deletion of affected genes.


2019 ◽  
Vol 132 (16) ◽  
pp. 2011-2012
Author(s):  
Ying-Zi Zhang ◽  
Da-Yong Bai ◽  
Zhan Qi ◽  
Su-Zhou Zhao ◽  
Xiu-Min Yang ◽  
...  

2017 ◽  
Vol 60 (4) ◽  
pp. 205-211 ◽  
Author(s):  
Noa Even-Zohar Gross ◽  
Talia Geva-Eldar ◽  
Yehuda Pollak ◽  
Harry J. Hirsch ◽  
Itai Gross ◽  
...  

Author(s):  
К.О. Карандашева ◽  
М.С. Пащенко ◽  
К.И. Аношкин ◽  
Е.Б. Кузнецова ◽  
А.С. Танас ◽  
...  

Исследование проведено на материале ДНК периферической крови 1000 пациентов с клиническими признаками нейрофиброматоза 1-го типа или нейрофиброматоза 2-го типа. Молекулярно-диагностический комплекс включал высокопроизводительное параллельное секвенирование, мультиплексную амплификацию лигированных зондов, секвенирование по Сэнгеру. Клинический диагноз был подтвержден в 70,2% случаев, мутации в генах NF1 и NF2 были выявлены у 672 и 30 пациентов соответственно. The study was conducted of DNA from peripheral blood of 1000 patients with clinical signs of neurofibromatosis type 1 or neurofibromatosis type 2. The genetic testing included massive parallel sequencing, multiplex ligation-dependent probe amplification, Sanger sequencing. The pathogenic mutation was identified in 70.2% of the cases, affecting NF1 and NF2 genes in 672 and 30 cases, respectively.


2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Chang Liu ◽  
Xiangzhong Zhang ◽  
Jicheng Wang ◽  
Yan Zhang ◽  
Anshi Wang ◽  
...  

2017 ◽  
Vol 36 (3) ◽  
pp. 134-141 ◽  
Author(s):  
Ylenia Abdilla ◽  
Maria Andria Barbara ◽  
Jean Calleja-Agius

AbstractThe imprinting disorder, Prader-Willi syndrome, is a condition associated with the gene region 15q11.2-q.13. The phenotype includes multiple characteristics, most of which are endocrine-related. An accurate diagnosis is done mostly through pre- or postnatal genetic testing. Management is mainly aimed at correcting the endocrine dysfunctions present in these patients. Genetic testing is also important to distinguish between the different causes and to calculate the recurrence risk for parents with affected children. Although a lot has been discovered and this syndrome can be managed to a satisfactory degree, further research is still important especially regarding new potential treatments with greater efficiency and reduced invasiveness. The neonatal nurse has an important role because the management requires thorough monitoring as well as high compliance from both the patient and the carers. Thus, it is essential for the neonatal nurse to have a good knowledge of this condition.


2021 ◽  
Author(s):  
Yang-Li Dai ◽  
Ke Huang ◽  
Ming-Qiang Zhu ◽  
Mian-Ling Zhong ◽  
Guan-Ping Dong ◽  
...  

Abstract BackgroundPrader-Willi syndrome (PWS) is a rare neurodevelopmental disorder that is partially caused by maternal uniparental disomy (UPD) of chromosome 15. Copy-neutral loss of heterozygosity (CN-LOH) observed on the distal long arm of chromosome 15 may be an indicator of UPD and may require additional genetic testing as chromosome 15 is known to harbor imprinted genes.MethodsChromosome microarray (CMA) was performed for two children with developmental disabilities or congenital anomalies. The results showed CN-LOH on the distal long arm of chromosome 15. Thereafter, methylation-specific PCR (MS-PCR) or methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) was performed to confirm the diagnosis of PWS.ResultsMS-PCR did not detect an unmethylated allele for the SNRPN gene or MS-MLPA hypermethylation in 15q11.2-q13.1 region, supporting the diagnosis of PWS.ConclusionsThese data suggested that LOH on chromosome 15, and even the critical region of 15q11.2q13.1 was not involved, perhaps due to partial heterodisomy and partial isodisomy UPD15. Hence, other genetic tests are warranted for the diagnosis of PWS.


2012 ◽  
Vol 16 (3) ◽  
pp. 178-186 ◽  
Author(s):  
Rebecca S. Henkhaus ◽  
Soo-Jeong Kim ◽  
Virginia E. Kimonis ◽  
June-Anne Gold ◽  
Elisabeth M. Dykens ◽  
...  

2020 ◽  
Author(s):  
Gaohong Wu ◽  
Dongya Yan ◽  
Meijuan Zhou ◽  
Wenmei Li ◽  
Ping Jiang ◽  
...  

Abstract Background: To investigate the pathogenesis and clinical characteristics of Oculocutaneous albinism type 2 (OCA2), a genetic condition in the etiology of Prader-Willi syndrome (PWS).Case presentation: A retrospective study of one case presented with poor response to stimuli, difficultfeeding, poor crying, with yellow hair and white skin. We performed genetic testing and investigated disease pathogenesis, clinical manifestations, and diagnosis, and discussed the characteristics of the disease through a literature review. HiSeq high-throughput sequencing result suggested a deletion with 105 genes, including UBE3A, SNRPN, OCA2, and other genes up to 5.18 Mb on the long arm of chromosome (15q11-13 region), a critical region, susceptible to the PWS. A paternally derived deletion Del (15q11. 2q13. 1) [GRCh37 / hg19] (23, 378, 392-28, 563, 050) × 1, and a maternal missense mutation were identified in the OCA2 gene (chr15: 28171296 c .2056G> A (p.A686T). During the period of hospitalization, the child still suffered from poor milk intake, and she was discharged from the hospital at the request of her parents. After discharge, the patient was followed up for two months by telephone. However, the patient died of feeding difficulties and pulmonary infection.Conclusions: OCA2 combined with PWS due to OCA2 gene missense mutation combined with large fragment deletion of 15q11-13 region was first reported in this study, of which the clinical signs can be subtle and symptoms can be more severe, therefore, early genetic testing is crucial for those patients to yield an accurate diagnosis and initiate aggressive interventions to optimize the outcomes.


2018 ◽  
Vol 159 (2) ◽  
pp. 64-69 ◽  
Author(s):  
Orsolya Dóra Ács ◽  
Bálint Péterfia ◽  
Péter Hollósi ◽  
Irén Haltrich ◽  
Ágnes Sallai ◽  
...  

Abstract: Introduction: According to the international literature, DNA methylation analysis of the promoter region of SNRPN locus is the most efficient way to start genetic investigation in patients with suspected Prader–Willi syndrome. Aim: Our aim was to develop a simple, reliable first-tier diagnosis to confirm Prader–Willi syndrome, therefore to compare our self-designed simple, cost-efficient high-resolution melting analysis and the most commonly used methylation-specific multiplex ligation-dependent probe amplification to confirm Prader–Willi syndrome. Method: We studied 17 clinically suspected Prader–Willi syndrome children and their DNA samples. With self-designed primers, bisulfite-sensitive polymerase chain reaction, high-resolution melting analysis and, as a control, methylation-specific multiplex ligation-dependent probe amplification were performed. Results: Prader–Willi syndrome was genetically confirmed in 6 out of 17 clinically suspected Prader–Willi syndrome patients. The results of high-resolution melting analysis and methylation-specific multiplex ligation-dependent probe amplification were equivalent in each case. Conclusion: Using our self-designed primers and altered bisulfite-specific PCR conditions, high-resolution melting analysis appears to be a simple, fast, reliable and effective method for primarily proving or excluding clinically suspected Prade-Willi syndrome cases. Orv Hetil. 2018; 159(2): 64–69.


Sign in / Sign up

Export Citation Format

Share Document